NASDAQ · Financial Statements
Pulse Biosciences, Inc (PLSE) Financial Statements
$53.81
NASDAQ: PLSE
Market Cap $3.72B
Overview Financials Dividend Pulse Biosciences, Inc most recently reported annual revenue of $0, net profit of $-73.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $1.0M $1.0M $0 $0 $0 Operating Profit $-63.0M $-58.0M $-44.0M $-56.0M $-77.0M Net Profit $-64.0M $-59.0M $-42.0M $-54.0M $-73.0M EPS $-2.28 $-1.72 $-0.88 $-0.92 $-1.08 Op Margin -4443.9% -8293.9% — — -21982.6%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $54.0M $78.0M $59.0M $132.0M $96.0M Total Liabilities $19.0M $80.0M $15.0M $18.0M $15.0M Cash $29.0M $61.0M $44.0M $118.0M $81.0M Borrowings $11.0M $76.0M $9.0M $9.0M $8.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-54.0M $-47.0M $-33.0M $-36.0M $-54.0M Investing Cash Flow $7.0M $-1.0M $0 $0 $-1.0M Financing Cash Flow $63.0M $0 $0 $50.0M $0 Net Cash Flow $16.0M $33.0M $-17.0M $74.0M $-37.0M Free Cash Flow $-55.0M $-47.0M $-33.0M $-36.0M $-54.0M
Valuation & Return Ratios
Metric Value PEG Ratio 4.36 EV / EBITDA -42.58 FCF Yield -1.76% Quick Ratio 9.61 Interest Coverage 0.00 Return 1Y 116.09% Return 3Y 392.63% Return 5Y 63.31%
Screens featuring this stock